Vol 4, No 2 (June 25, 2015): Chinese Clinical Oncology (Brain Metastases - Guest Editors: Michael Weller, Matthias Preusser)

Review Article

Prognostic scores for brain metastasis patients: use in clinical practice and trial design
Vyshak Alva Venur, Manmeet S. Ahluwalia
Neurosurgical and radiosurgical decision making in brain metastasis patients in the area of targeted therapies?
Philippe Metellus, Emilie Bialecki, Emilie Le Rhun, Frederic Dhermain
Anaplastic lymphoma kinase inhibitors in brain metastases from ALK+ non-small cell lung cancer: hitting the target even in the CNS
Samuel J. Klempner, Sai-Hong Ignatius Ou
The inflammatory microenvironment in brain metastases: potential treatment target?
Anna S. Berghoff, Matthias Preusser
Genomic profiling of brain metastases: current knowledge and new frontiers
Martha R. Neagu, Corey M. Gill, Tracy T. Batchelor, Priscilla K. Brastianos
The emerging role of advanced neuroimaging techniques for brain metastases
Martha Nowosielski, Alexander Radbruch
Strategies for preservation of memory function in patients with brain metastases
Nicholas B. Dye, Vinai Gondi, Minesh P. Mehta
Systemic therapies for melanoma brain metastases: which drug for whom and when?
Sangeetha Ramanujam, Dirk Schadendorf, Georgina V. Long
Management of neoplastic meningitis
Patrick Roth, Michael Weller


The focused issue “Brain Metastases” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Michael Weller and Matthias Preusser served as the unpaid Guest Editors for the focused issue.